Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 18, 2021Advances in TherapyOpen Access

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

View Full Paper
Ask AI
Bookmark
Share

Authors

CNCarrie M. NielsonGilead Sciences (Canada)ABAlexander BreskinRegeneron (United States)BSBradley SaulUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nielson et al. (2021) studied this question.

synapsesocial.com/papers/6a968dd431394ac286fbc412https://doi.org/10.1007/s12325-021-01727-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dynamic secondary electron emission in rough composite materials2019 · 54 citations
  2. 2Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies2003 · 98 citations
  3. 3Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles2019 · 8,527 citations
  4. 4Nonparametric Estimation of Partial Transition Probabilities in Multiple Decrement Models1978 · 303 citations
  5. 5Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group2008 · 2,709 citations